A solid-state approach to enable early d
โ
David Engers; Jing Teng; Jonathan Jimenez-Novoa; Philip Gent; Stuart Hossack; Ch
๐
Article
๐
2010
๐
John Wiley and Sons
๐
English
โ 436 KB
A solid-state approach to enable compounds in preclinical development is used by identifying an amorphous solid dispersion in a simple formulation to increase bioavailability. Itraconazole (ITZ) was chosen as a model crystalline compound displaying poor aqueous solubility and low bioavailability. So